James Morton

1.2k total citations
22 papers, 464 citations indexed

About

James Morton is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, James Morton has authored 22 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 8 papers in Oncology and 7 papers in Immunology. Recurrent topics in James Morton's work include Hematopoietic Stem Cell Transplantation (12 papers), Multiple Myeloma Research and Treatments (5 papers) and Immune Cell Function and Interaction (4 papers). James Morton is often cited by papers focused on Hematopoietic Stem Cell Transplantation (12 papers), Multiple Myeloma Research and Treatments (5 papers) and Immune Cell Function and Interaction (4 papers). James Morton collaborates with scholars based in Australia, United States and Japan. James Morton's co-authors include Simon Durrant, Cheryl Hutchins, Glen Kennedy, Jason Butler, Geoffrey R. Hill, S. T. S. Durrant, Siok‐Keen Tey, Tania Crough, Rajiv Khanna and Ashish Misra and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

James Morton

21 papers receiving 461 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James Morton Australia	12	329	136	134	96	85	22	464
Fábio R. Kerbauy Brazil	11	291 0.9×	87 0.6×	153 1.1×	53 0.6×	76 0.9×	45	474
Sandeep Nagra United Kingdom	13	351 1.1×	134 1.0×	143 1.1×	65 0.7×	59 0.7×	21	518
Nobuyuki Aotsuka Japan	14	538 1.6×	163 1.2×	180 1.3×	75 0.8×	136 1.6×	67	695
Moreno Festuccia Italy	15	324 1.0×	127 0.9×	156 1.2×	107 1.1×	58 0.7×	34	529
Fanny Rialland France	13	282 0.9×	104 0.8×	176 1.3×	116 1.2×	69 0.8×	45	490
Anne Marie Gonzales United States	9	224 0.7×	167 1.2×	180 1.3×	120 1.3×	72 0.8×	13	469
Mateja Kralj Juric Austria	6	249 0.8×	207 1.5×	96 0.7×	85 0.9×	53 0.6×	7	454
Gergely Kriván Hungary	12	157 0.5×	158 1.2×	114 0.9×	114 1.2×	45 0.5×	58	449
D. Macdonald United Kingdom	12	202 0.6×	134 1.0×	103 0.8×	56 0.6×	137 1.6×	14	475
Alexei Maschan Russia	12	405 1.2×	225 1.7×	151 1.1×	66 0.7×	61 0.7×	31	567

Countries citing papers authored by James Morton

Since Specialization

Citations

This map shows the geographic impact of James Morton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Morton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Morton more than expected).

Fields of papers citing papers by James Morton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Morton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Morton. The network helps show where James Morton may publish in the future.

Co-authorship network of co-authors of James Morton

This figure shows the co-authorship network connecting the top 25 collaborators of James Morton. A scholar is included among the top collaborators of James Morton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Morton. James Morton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nath, Karthik, Debra L. Taylor, Robert S. Ware, et al.. (2022). Activity and outcomes of autologous stem cell transplantation in the private sector in Australia. Internal Medicine Journal. 53(6). 923–929.

Kennedy, Glen, Siok‐Keen Tey, Cameron Curley, et al.. (2019). Results of a Phase III Double-Blind Study of the Addition of Tocilizumab Vs. Placebo to Cyclosporin/Methotrexate Gvhd Prophylaxis after HLA-Matched Allogeneic Stem Cell Transplantation. Blood. 134(Supplement_1). 368–368. 6 indexed citations

Kaufman, Jonathan L., Meletios Α. Dimopoulos, Merav Leiba, et al.. (2019). Efficacy and safety of daratumumab, lenalidomide, and dexamethasone (D-Rd) in relapsed or refractory multiple myeloma (RRMM): Updated subgroup analysis of POLLUX based on cytogenetic risk.. Journal of Clinical Oncology. 37(15_suppl). 8038–8038. 5 indexed citations

Moreau, Philippe, Donald B. White, Lotfi Benboubker, et al.. (2018). Updated efficacy and safety analysis of daratumumab, lenalidomide, and dexamethasone (DRd) versus lenalidomide and dexamethasone (Rd) for relapsed or refractory multiple myeloma (rrmm; pollux). White Rose Research Online (University of Leeds, The University of Sheffield, University of York). 1 indexed citations

Usmani, Saad Z., Meletios Α. Dimopoulos, Andrew Belch, et al.. (2016). Efficacy of Daratumumab, Lenalidomide, and Dexamethasone Versus Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma Patients with 1 to 3 Prior Lines of Therapy: Updated Analysis of Pollux. Blood. 128(22). 1151–1151. 22 indexed citations

Gopal, Ajay K., Stephen J. Schuster, Nathan Fowler, et al.. (2016). Ibrutinib As Treatment for Chemoimmunotherapy-Resistant Patients with Follicular Lymphoma: First Results from the Open-Label, Multicenter, Phase 2 DAWN Study. Blood. 128(22). 1217–1217. 5 indexed citations

Tey, Siok‐Keen, Glen Kennedy, Deborah Cromer, et al.. (2013). Clinical Assessment of Anti-Viral CD8+ T Cell Immune Monitoring Using QuantiFERON-CMV® Assay to Identify High Risk Allogeneic Hematopoietic Stem Cell Transplant Patients with CMV Infection Complications. PLoS ONE. 8(10). e74744–e74744. 67 indexed citations

Kennedy, Glen, Antiopi Varelias, Slavica Vučković, et al.. (2013). The Addition Of Interleukin-6 Inhibition To Standard Gvhd Prophylaxis Prevents Acute Gvhd: Interim Results Of a Phase I/II Clinical Study. Blood. 122(21). 908–908. 4 indexed citations

Hill, Geoffrey R., Siok‐Keen Tey, Leone Beagley, et al.. (2009). Successful Immunotherapy of HCMV Disease Using Virus‐Specific T Cells Expanded from an Allogeneic Stem Cell Transplant Recipient. American Journal of Transplantation. 10(1). 173–179. 24 indexed citations

10.

Kennedy, Glen, Jason Butler, James Morton, et al.. (2006). Myeloablative allogeneic stem cell transplantation for advanced stage multiple myeloma: very long-term follow up of a single center experience. Clinical & Laboratory Haematology. 28(3). 189–197. 7 indexed citations

11.

Kennedy, Glen, et al.. (2006). Combination antithymocyte globulin and soluble TNFα inhibitor (etanercept) +/− mycophenolate mofetil for treatment of steroid refractory acute graft-versus-host disease. Bone Marrow Transplantation. 37(12). 1143–1147. 40 indexed citations

12.

Hill, Geoffrey R., Edward S. Morris, Cheryl Hutchins, et al.. (2006). Allogeneic Stem Cell Transplantation with Peripheral Blood Stem Cells Mobilized by Pegylated G-CSF. Biology of Blood and Marrow Transplantation. 12(6). 603–607. 30 indexed citations

13.

Morton, James, Julia L. Newton, & Christopher S. Gray. (2005). Counting the true cost of antiplatelet therapy for stroke prevention. Age and Ageing. 34(3). 212–214. 2 indexed citations

14.

Kennedy, Glen, et al.. (2005). Efficacy of Soluble TNFα Inhibitor (Etanercept) for Treatment of Steroid Refractory Acute Graft Versus Host Disease (GVHD) Post Allogeneic Stem Cell Transplantation (SCT).. Blood. 106(11). 1806–1806. 1 indexed citations

15.

Kennedy, Glen, et al.. (2003). Impact of stem cell donation modality on normal donor quality of life: a prospective randomized study. Bone Marrow Transplantation. 31(11). 1033–1035. 25 indexed citations

16.

Ritchie, David, James Morton, Jeff Szer, et al.. (2003). Graft-versus-host disease, donor chimerism, and organ toxicity in stem cell transplantation after conditioning with fludarabine and melphalan. Biology of Blood and Marrow Transplantation. 9(7). 435–442. 16 indexed citations

17.

Dicker, Tony, et al.. (2002). Myeloma‐associated systemic amyloidosis presenting with acquired digital cutis laxa‐like changes. Australasian Journal of Dermatology. 43(2). 144–146. 18 indexed citations

18.

Morton, James, Darren P. Baker, Cheryl Hutchins, & S. T. S. Durrant. (1997). The COBE Spectra cell separator is more effective than the Haemonetics MCS‐3P cell separator for peripheral blood progenitor cell harvest after mobilization with cyclophosphamide and filgrastim. Transfusion. 37(6). 631–633. 17 indexed citations

19.

Morton, James, et al.. (1997). Predictors for optimal mobilization and subsequent engraftment of peripheral blood progenitor cells following intermediate dose cyclophosphamide and G-CSF. Leukemia Research. 21(1). 21–27. 25 indexed citations

20.

Taylor, Kerry, R. Rodwell, Debra L. Taylor, et al.. (1995). Normal (RT-PCR negative) stem cells can be collected following lenograstim therapy in chronic myeloid leukemia (CML) in major/complete cytogenetic response (MCR/CCR) on alpha-interferon (alpha-IFN).. Blood. 86(10). 3955–3955. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact